Source: Eur Respir J 2016; 47: 342-343



Rating:

Share or cite this content

Citations should be made in the following way:
Currow David C., Abernethy Amy P., Allcroft Peter, Banzett Robert B., Bausewein Claudia, Booth Sara, Carrieri-Kohlman Virginia, Davidson Patricia, Disler Rebecca, Donesky DorAnne, Dudgeon Deborah, Ekstrom Magnus, Farquhar Morag, Higginson Irene, Janssen Daisy, Jensen Dennis, Jolley Caroline, Krajnik Malgorzata, Laveneziana Pierantonio, McDonald Christine, Maddocks Matthew, Morelot-Panzini Capucine, Moxham John, Mularski Richard A., Noble Simon, O'Donnell Denis, Parshall Mark B., Pattinson Kyle, Phillips Jane, Ross Joy, Schwartzstein Richard M., Similowski Thomas, Simon Steffen T., Smith Tracy, Wells Athol, Yates Patsy, Yorke Janelle, Johnson Miriam J.. The need to research refractory breathlessness. Eur Respir J 2016; 47: 342-343

Member's Comments

No comment yet.

Related content which might interest you: Might a short-term telerehabilitation program improve effort tolerance, dyspnea, and effort desaturation in patients discharged after COVID-19 pneumonia? Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19 Year: 2021 Group-delivered speech and language therapy for chronic refractory cough: what do patients want? Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019 Treating anxious expectations can improve dyspnoea in patients with COPD Source: Eur Respir J, 50 (3) 1701352; 10.1183/13993003.01352-2017 Year: 2017 Managing breathlessness with a comprehensive pulmonary rehabilitation programme Source: International Congress 2019 – Clinical Grand Round Year: 2019 Management of refractory dyspnoea in end-stage patients: the use of noninvasive respiratory support Source: Virtual Congress 2021 – Noninvasive respiratory support in hypoxic respiratory failure: stay safe and know your limits Year: 2021 Effectiveness of a nurse practitioner coordinated multidisciplinary rapid access clinic in patients with chronic dyspnea, a pilot-study Source: Annual Congress 2006 - Effective strategies for chronic respiratory patient management Year: 2006 Effectiveness of a breathlessness service for patients suffering from breathlessness in advanced disease: pragmatic fast-track randomized controlled trial Source: Virtual Congress 2020 – New and integrated tools for respiratory diagnosis and care Year: 2020 The clinical management of exertional dyspnoea in patients with cardiorespiratory diseases Source: Research Seminar 2012 - Dyspnoea: multidimensional and multidisciplinary Year: 2012 The impact of dyspnoea and strategies used by lung fibrosis patients to relieve breathlessness. Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017 A systematic review of nursing interventions for breathlessness in COPD Source: International Congress 2017 – Patient experience of smoking cessation: new approaches Year: 2017 Is nebulized morphine effective in treating persistent dyspnea in very severe COPD? A preliminary report Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 General practitioners’ beliefs and experiences when caring for patients with severe chronic obstructive pulmonary disease and refractory breathlessness Source: International Congress 2017 – Primary care management of asthma and COPD Year: 2017 Management of refractory dyspnoea in COPD Source: Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening Year: 2021 Non-pharmacological management of dyspnoea and cough in COPD Source: International Congress 2014 – Primary Care Programme "Management of COPD and other respiratory conditions in clinical practice" Year: 2014 A digital therapy for proactively managing exacerbations and delivering therapeutic benefit to patients with moderate to severe asthma Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 Predictable adverse events such as respiratory depression highlight the need for caution when prescribing morphine for refractory breathlessness Source: Eur Respir J, 50 (3) 1701357; 10.1183/13993003.01357-2017 Year: 2017 Does use of the hyperventilation provocation test alter management of patients with unexplained breathlessness? Source: Annual Congress 2009 - Accuracy in lung function testing Year: 2009 Pharmacology for palliative care in chronic lung disease Source: Annual Congress 2006 - PG10 - Preparation and palliation for end-of-life in chronic respiratory disease Year: 2006 Non-pharmacological interventions for the management of breathlessness Source: International Congress 2018 – Dyspnoea: a multidimensional and multidisciplinary approach Year: 2018